Skip to main content
. 2020 Dec 9;296:100157. doi: 10.1074/jbc.RA120.014960

Table 3.

SynergyFinder scores from NF2-null meningioma lines co-treated with INK128 and BMS-754807

Cell line Modela SynergyFinder
Average score Most synergistic area score
Ben-Men-1 (immortalized MN) HSA 9.99 24.79
Ben-Men-1 (immortalized MN) Loewe 8.98 21.78
Ben-Men-1 (immortalized MN) Bliss 8.84 21.98
Ben-Men-1 (immortalized MN) ZIP 8.85 21.30
MN1-LF (immortalized MN) HSA 9.55 25.76
MN1-LF (immortalized MN) Loewe 9.14 21.27
MN1-LF (immortalized MN) Bliss 10.21 22.52
MN1-LF (immortalized MN) ZIP 10.26 22.76
MN646 C (primary MN) HSA 8.69 18.78
MN646 C (primary MN) Loewe 7.84 17.38
MN646 C (primary MN) Bliss 9.02 22.64
MN646 C (primary MN) ZIP 9.04 21.71
MN658 (primary MN) HSA 9.36 21.29
MN658 (primary MN) Loewe 9.00 19.87
MN658 (primary MN) Bliss 8.14 20.92
MN658 (primary MN) ZIP 8.14 20.86

MN, meningioma.

a

Synergy reference models: HSA, highest single agent; Loewe, Loewe additivity; Bliss, Bliss independence; ZIP, zero interaction potency.